Clinical Trial Update: EuroNetrod HTN OFF-Med Study of Renal Denervation With NetrodTM Six-electrode Radiofrequency RDN System [NA]

View source ↗

Summary

The EuroNetrod HTN OFF-Med study evaluating the Netrod six-electrode renal denervation system for uncontrolled hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Shanghai Golden Leaf MedTec Co. Ltd | Conditions: Uncontrolled Hypertension | NA | Status: WITHDRAWN